Acadia Pharmaceuticals reported $204.92M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 204.92M 57.48M
ALKERMES ALKS:US $ 282.56M 54.99M
Alnylam Pharmaceuticals ALNY:US $ 534.08M 285.89M
Aptinyx Inc APTX:US $ 100.16M 5.96M
Biogen BIIB:US $ 1749.3M 512.1M
Biomarin Pharmaceutical BMRN:US $ 605.44M 18.16M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Cara Therapeutics CARA:US $ 21.36M 7.91M
Corcept Therapeutics CORT:US $ 61.86M 15.76M
Cytokinetics CYTK:US $ 115.42M 2.76M
Eisai 4523:JP Y 309633M 51213M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Intercept Pharmaceuticals ICPT:US $ 48.32M 36.39M
Intra Cellular Therapies ITCI:US $ 129.29M 36.93M
Johnson & Johnson JNJ:US $ 1579M 322M
Marinus Pharmaceuticals MRNS:US $ 126.32M 3.39M
Moderna Inc MRNA:US 5.05B 1.8B
Neurocrine Biosciences NBIX:US $ 270.2M 70.6M
Pfizer PFE:US $ 2470M 526M
Prothena PRTA:US $ 542.99M 36.1M
Ptc Therapeutics PTCT:US $ 144.18M 45.54M
Sarepta Therapeutics SRPT:US $ 1233.88M 881.99M
Seattle Genetics SGEN:US $ 261M 163.84M
Ultragenyx Pharmaceutical RARE:US $ 153.99M 153.6M
Vanda Pharmaceuticals VNDA:US $ 66.93M 14.86M
Vertex Pharmaceuticals VRTX:US $ 7600.1M 805.1M
YTE INCY:US $ 2256.76M 199.32M